| Dr Robert James Bess, MD | |
|
7800 E Orchard Rd, 350, Greenwood Village, CO 80111-2583 | |
| (303) 788-5230 | |
| (303) 862-8773 |
| Full Name | Dr Robert James Bess |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 45 Years |
| Location | 7800 E Orchard Rd, Greenwood Village, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083672570 | NPI | - | NPPES |
| BEB5168 | Other | CO | BCBS |
| OR662087 | Other | CO | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MD23167 (Colorado) | Primary |
| Entity Name | Robert Bess Md, Facs Orthopaedic Surgery Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912183625 PECOS PAC ID: 3870560246 Enrollment ID: O20040914001410 |
News Archive
Researchers from the Huazhong University of Science and Technology and Shanghai Jiao Tong University, China, recently built a proteome microarray with 20 out of the 28 predicted SARS-CoV-2 proteins to help understand IgM/IgG responses specific to SARS-CoV-2.
In addition to the Chamber's approach, news outlets detailed the National Taxpayers' Union plans once the repeal vote is over to focus on certain tax provisions in the new law that the Obama administration may be willing to address. Also, experts on Minnesota Public Radio discuss the political positioning and implementation action at the state level.
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced its intention during the 2009 fourth quarter to submit a revised protocol for its planned Phase IIb clinical trial for arimoclomol as a treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). The decision follows receipt of an anticipated written letter from the U.S.
Michael Jaffe, a professor of biomedical engineering at NJIT, has received a patent for a chemical derived from sugar. This new material is a derivative of isosorbide and may be able to replace bisphenol A (BPA) in a number of consumer products, including the lining of tin cans.
Technology may be the key to identifying high-risk behaviors among adolescents. Injury risk, depressive symptoms and drug and alcohol use are the leading causes of adolescent morbidity and mortality; yet pediatricians often lack the time to screen for these behavioral concerns.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert James Bess, MD 7800 E Orchard Rd, 350, Greenwood Village, CO 80111-2583 Ph: (303) 788-5230 | Dr Robert James Bess, MD 7800 E Orchard Rd, 350, Greenwood Village, CO 80111-2583 Ph: (303) 788-5230 |
News Archive
Researchers from the Huazhong University of Science and Technology and Shanghai Jiao Tong University, China, recently built a proteome microarray with 20 out of the 28 predicted SARS-CoV-2 proteins to help understand IgM/IgG responses specific to SARS-CoV-2.
In addition to the Chamber's approach, news outlets detailed the National Taxpayers' Union plans once the repeal vote is over to focus on certain tax provisions in the new law that the Obama administration may be willing to address. Also, experts on Minnesota Public Radio discuss the political positioning and implementation action at the state level.
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced its intention during the 2009 fourth quarter to submit a revised protocol for its planned Phase IIb clinical trial for arimoclomol as a treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). The decision follows receipt of an anticipated written letter from the U.S.
Michael Jaffe, a professor of biomedical engineering at NJIT, has received a patent for a chemical derived from sugar. This new material is a derivative of isosorbide and may be able to replace bisphenol A (BPA) in a number of consumer products, including the lining of tin cans.
Technology may be the key to identifying high-risk behaviors among adolescents. Injury risk, depressive symptoms and drug and alcohol use are the leading causes of adolescent morbidity and mortality; yet pediatricians often lack the time to screen for these behavioral concerns.
› Verified 7 days ago
Dr. Gary Ghiselli, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7800 E Orchard Rd, Suite 100, Greenwood Village, CO 80111 Phone: 303-783-1300 Fax: 303-783-1200 | |
Jennifer L Kummer, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8200 E Belleview Ave, Ste 615, Greenwood Village, CO 80111 Phone: 303-694-3333 | |
Dr. Nicole F Einhorn, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 7350 E Progress Pl, Ste 201, Greenwood Village, CO 80111 Phone: 720-282-4707 Fax: 303-539-4767 | |
Dr. Joshua Ariel Metzl, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8200 E Belleview Ave, Ste 615, Greenwood Village, CO 80111 Phone: 303-694-3333 Fax: 303-694-9666 | |
Dr. Myron Richard Kem, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1 Canon Dr, Greenwood Village, CO 80111 Phone: 303-753-0253 Fax: 303-759-4562 | |
Martin Boublik, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8200 E Belleview Ave, Ste 615, Greenwood Village, CO 80111 Phone: 303-694-3333 |